Vital Signsby Bridgehead

02  Who is talking  ·  pick a lens

03  The signal  ·  Where it is spoken from

607

of 1,439 MPs & peers have spoken on cancer since 9 July 2024 · 1,956 Commons contributions from 419 constituencies · latest sitting indexed 11 September 2026

0Hansard contributions per seat80

Seats shaded by Hansard contributions on this topic. Lines join the 9 MPs in this list to their constituencies; peers have no seat and no line.

#Most activeSignalScore
  1. 01Clive JonesSpokespersonLiberal Democrat · Wokingham · Commons · Liberal Democrat Spokesperson (Trade)240
  2. 02Ashley DaltonLabour · West Lancashire · Commons225
  3. 03Jim ShannonDemocratic Unionist Party · Strangford · Commons216
  4. 04Dr Caroline JohnsonShadowConservative · Sleaford and North Hykeham · Commons · Shadow Minister (Health and Social Care)174
  5. 05Baroness MerronMinisterLabour · House of Lords · Parliamentary Under-Secretary (Department of Health and Social Care)158
  6. 06Wes StreetingCabinetLabour · Ilford North · Commons · Secretary of State for Defence135
  7. 07Karin SmythMinisterLabour · Bristol South · Commons · Minister of State (Department of Health and Social Care)132
  8. 08Helen MorganSpokespersonLiberal Democrat · North Shropshire · Commons · Liberal Democrat Spokesperson (Health and Social Care)93
  9. 09Sir Keir StarmerLabour · Holborn and St Pancras · Commons84
  10. 10Dr Scott ArthurLabour · Edinburgh South West · Commons81

Score is a weighted Hansard contribution score for this topic since 9 July 2024. Portraits: UK Parliament Members API. Rank change (▲/▼) is vs. 7 days ago.

Hansard · weekly mentions

371 mentions in the last 8 sitting weeks, 227 in the 8 before

RecessJan 25Jul 25Jan 26Jul 26100 · w/c 3 Feb57 · w/c 7 Sep

Recess weeks are not counted: sitting weeks are compared with sitting weeks, and the current week is left off until it is complete. Parliament was in recess 27 Jul to 30 Aug 2026. 2,704 mentions since 9 July 2024.

Press · articles per week

188 articles in 25 weeks, 92 of them in the last five

AprMayJunJulAugSep53 · w/c 7 Sep

Source: Guardian archive, trade press and news search: a sample of coverage, not an exhaustive count. Weekly article counts to w/c 7 Sept; weeks not yet ingested are dropped rather than shown as zero.

Parliament · party split

Share of scored contributions

  • Labour311 members53%
  • Liberal Democrat82 members19%
  • Conservative131 members16%
  • Democratic Unionist Party7 members4%
  • Others (13 groups)76 members8%

Labour members account for 53% of the scored contributions on this topic, across 17 party groups in both Houses.

Parliament · reach

Members who have spoken

607of 1,439 MPs & peers

42% of the roster has spoken on this topic since 9 July 2024: one square per member, 419 MPs (navy) and 188 peers (cobalt).

Briefing · Parliament

MPs and peers debate cancer waiting times, radiotherapy access and funding for lobular breast cancer research

  1. The Health Bill's Report Stage generated the most sustained cancer-specific argument. Tim Farron (Liberal Democrat, Westmorland and Lonsdale) and Grahame Morris (Labour, Easington) pressed new clauses that would have created a legal right to begin cancer treatment within 62 days of referral and established a national radiotherapy framework, with Morris noting that only 35% of UK cancer patients received radiotherapy as part of primary treatment. Minister Karin Smyth (Labour, Bristol South) declined to accept the new clauses, pointing to the national cancer plan and the national cancer board as the Government's preferred accountability mechanism.
  2. The Lobular Breast Cancer Moon Shot Project debate in Westminster Hall on 9 July saw cross-party calls for the Government to ringfence £20 million over five years for research into invasive lobular breast cancer, with John Milne (Liberal Democrat, Horsham) and others paying tribute to campaigner Dr Susan Michaelis on the first anniversary of her death. Minister Stephen Kinnock (Labour, Aberafan Maesteg) refused to commit to ringfencing, saying competitive peer-reviewed applications were the standard process, though he acknowledged he would follow up on the status of live research bids.
  3. At the final Commons sitting before recess, on 11 September, the Terminally Ill Adults (End of Life) Bill prompted Members with direct cancer experience to speak. Ashley Dalton (Labour, West Lancashire), who disclosed a stage 4 metastatic breast cancer diagnosis, said she had considered that dying quickly might be easier on her family. Dr Zubir Ahmed (Labour, Glasgow South West), a practising cancer surgeon, argued as a sceptic that the six-month prognosis threshold would take an 'unhealthy salience in every clinical conversation', while Dr Peter Prinsley (Labour, Bury St Edmunds and Stowmarket) and Andrew Lewin (Labour, Welwyn Hatfield) argued that some cancer deaths were so distressing that the Bill was necessary.
  4. Access to cancer treatment for people in rural and coastal areas came up repeatedly. Richard Quigley (Labour, Isle of Wight West) described residents abandoning treatment because of travel costs across the Solent. Ben Maguire (Liberal Democrat, North Cornwall) detailed constituents making six-hour round trips by bus for chemotherapy, and Dan Aldridge (Labour, Weston-super-Mare) noted his town had no radiotherapy machine despite its size, while Tom Gordon (Liberal Democrat, Harrogate and Knaresborough) highlighted that clinical research funding in Yorkshire was about a quarter of what London received.
  5. The debate on diethylstilbestrol on 29 June, led by Jessica Toale (Labour, Bournemouth West), raised concerns that routine cervical smear tests do not reliably detect the rare cancer associated with DES exposure, leaving affected women unprotected. Minister Preet Kaur Gill (Labour, Birmingham Edgbaston) confirmed the Department had commissioned the University of Exeter to conduct a systematic evidence review, and that the national clinical director for cancer had written to all cancer alliance leaders in December 2025 to raise awareness among clinicians.

Verbatim

  • I was told that I have stage 4 incurable metastatic breast cancer. I was overwhelmed with grief, fear and anxiety; I was scared of what was to come, and fearful of how it would impact my family and my loved ones. I was scared that I was going to get really poorly and thinking, "How will I cope? How will my family cope? How will I be cared for? How will I afford it? How badly will it hurt? How long will it last?"

    Ashley Dalton · Labour, West Lancashire · Terminally Ill Adults (End of Life) Bill · 11 Sept 2026
    Read in Hansard (opens in a new tab)

  • In my practice, if a patient comes to see me with stage 4 colon cancer that has spread to their liver, the advent of immunotherapy means that I have an equal chance of telling them they have six months to live or six years to live. Under this law, when I meet that kind of patient, it is unclear to me, with the Supreme Court precedents around consent, whether I should be offering them immunotherapy and an assisted death at the same sitting.

    Dr Zubir Ahmed · Labour, Glasgow South West · Terminally Ill Adults (End of Life) Bill · 11 Sept 2026
    Read in Hansard (opens in a new tab)

  • We know the international consensus is that around half of all cancer patients have an evidence-based indication for radiotherapy at some point in their treatment. We should be aware that here in the United Kingdom in 2021, the last date for which figures were available, only 35% of cancer patients received it as part of their primary treatment.

    Grahame Morris · Labour, Easington · Health Bill · 8 Sept 2026
    Read in Hansard (opens in a new tab)

  • Current routine smear testing for cervical cancer is designed primarily to deal with and detect changes linked to HPV. It does not reliably detect clear cell adenocarcinoma—the rare cancer associated with DES exposure. That means many DES daughters may believe that they are being adequately screened, but in fact the very cancers for which they have an increased risk will not be picked up through the standard process.

    Jessica Toale · Labour, Bournemouth West · Diethylstilbestrol: Intergenerational Impact · 29 Jun 2026
    Read in Hansard (opens in a new tab)

AI-drafted from 197 Hansard contributions over 28 sitting days · 25 June 2026 to 11 September 2026 · No sittings were recorded between 24 July 2026 and 31 August 2026. · quotes are exact copies of the Hansard record, speakers taken from the record · generated 13 Sept 2026 · how briefings are made

Expert voices · press citations

The most quoted voices on this topic

40 of 189 expert voices, 82 citations across 5 groups. Click a group to open it as a lens on the map.

Clinicians

15 · 30 citationsOpen lens ↑

Academics

14 · 26 citationsOpen lens ↑

Sector leaders

9 · 24 citationsOpen lens ↑

Regulators & officials

1 · 1 citationOpen lens ↑

Unions

1 · 1 citationOpen lens ↑

Methodology

How Vital Signs ranks

Parliament. Every Hansard contribution on a topic since 9 July 2024 is scored by type and summed per member; the map colours each constituency by how often its MP has raised the topic. Peers sit in no constituency and are ranked but not mapped.

Press.Bylines rank journalists and quotations rank expert voices, across the Guardian archive and trade press Vital Signs has read. A voice’s pin marks its organisation’s base, never the person’s home.

Briefings. Drafted by an AI model from the underlying Hansard text or articles. Every quotation in a Parliament briefing is an exact copy of the Hansard record and linked to it; press quotations are as the linked articles reported them. The speaker is always taken from the record, not the model.